ALRN - Aileron Therapeutics: Low Cash Balance Early Stage But Scientific Premise Is Interesting February, 10 2021 03:46 AM Aileron Therapeutics Inc. Aileron Therapeutics has a long history of not doing much. Its data is early stage, but the scientific theory is interesting. The company needs cash. For further details see: Aileron Therapeutics: Low Cash Balance, Early Stage, But Scientific Premise Is Interesting